CONSTANT LEVERAGE LONG - UCB Share Price

A6YFB

NLBNPNL1Q9N4

Market Closed - Euronext Paris 07:15:00 16/05/2024 BST
11.94 ^EUR	+0.21%

Current month	-5.92%
1 month	+9.27%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart UCB

Latest news about UCB

UCB - Acquisition of own shares	05-13	AQ
UCB : Acquisition of own shares	05-10	PU
UCB presents final open-label extension F data at International Child Neurology Congress Annual Meeting	05-09	AQ
UCB : presents final open-label extension F®▼(fenfluramine) data at International Child Neurology Congress (ICNC) Annual Meeting	05-08	PU

More news

Quotes 5-day view

Date	Price	Change
16/05/24	11.94	+0.21%
15/05/24	11.91	+6.10%
14/05/24	11.22	-4.18%
13/05/24	11.72	-2.74%
10/05/24	12.04	+10.66%

Real-time Euronext Paris

Last update May 16, 2024 at 07:15 am

More quotes

Static data

Product type	Produits Exotiques
Buy / Sell	CALL
Underlying	UCB
Issuer	BNP Paribas
	A6YFB
ISIN	NLBNPNL1Q9N4
Date issued	09/03/2022
Maturity	Unlimited
Parity	1 : 1
Emission price	- €
Emission volume	N/A
Settlement	règlement en espèces
Currency	EUR

Technical Indicators

Highest since issue	18.05 €
Lowest since issue	2.08 €
Spread	0.54 €
Spread %	4.43%

Company Profile

UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.

Sector

More about the company

Ratings for UCB

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: UCB

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

122.6 EUR

Average target price

125.5 EUR

Spread / Average Target

+2.40%

Consensus